ANDROMEDA trial

hcplive_logo.png
Combination Therapy Holds Promise for Newly Diagnosed Systemic AL Amyloidosis Patients
Updated research regarding the ANDROMEDA study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, indicated the…
Read more
Ray Comenzo, MD, Discusses ANDROMEDA Trial in AL Amyloidosis Patients
The ANDROMEDA trial is a trial that is extremely important for patients who have systemic light chain or AL-amyloidosis. I'd like to begin by thanking Janssen…
Read more
Subscribe to